Medpace Holdings, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.1B | $1.9B | $1.5B | $1.1B |
| Operating income | $534.9M | $446.9M | $336.8M | $278.7M | $198.6M |
| Cash from operations | $713.2M | $608.8M | $433.4M | $388.1M | $263.3M |
| Capital expenditure | $31.4M | $36.5M | $36.6M | $36.9M | $28.3M |
| Free cash flow | $681.9M | $572.3M | $396.7M | $351.2M | $235.1M |
| Share repurchases | $917.4M | $169.9M | $144.0M | $847.8M | $62.1M |
| Total assets | $2.0B | $2.1B | $1.7B | $1.4B | $1.7B |
| Total liabilities | $1.5B | $1.3B | $1.1B | $966.1M | $707.0M |
Shares outstanding 28.6M · Free float 79.2%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.